{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:32:15Z","timestamp":1790937135264,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.vaccine.2007.08.035","type":"journal-article","created":{"date-parts":[[2007,9,6]],"date-time":"2007-09-06T20:07:38Z","timestamp":1189109258000},"page":"7540-7548","source":"Crossref","is-referenced-by-count":35,"title":["Protective immunity against botulism provided by a single dose vaccination with an adenovirus-vectored vaccine"],"prefix":"10.1016","volume":"25","author":[{"given":"Mingtao","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md.","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Pichichero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance L.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2007.08.035_bib1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1128\/iai.30.3.656-660.1980","article-title":"Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains","volume":"30","author":"Oguma","year":"1980","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2007.08.035_bib2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management","volume":"285","author":"Arnon","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2007.08.035_bib3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4049\/jimmunol.84.4.384","article-title":"Studies on immunity to toxins of Clostridium botulinum. V. Detoxification of purified type A and type B toxins, and the antigenicity of univalent and bivalent aluminium phosphate adsorbed toxoids","volume":"84","author":"Wright","year":"1960","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.08.035_bib4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4049\/jimmunol.90.5.697","article-title":"Studies on immunity to toxins of Clostridium botulinum. IX. Immunologic response of man to purified pentavalent ABCDE botulinum toxiod","volume":"90","author":"Fiock","year":"1963","journal-title":"J Immunol"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2007.08.035_bib5","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0300-9084(00)01173-1","article-title":"Development of vaccines for prevention of botulism","volume":"82","author":"Byrne","year":"2000","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.035_bib6","first-page":"59","article-title":"Analysis of the immune response to papain digestion products of tetanus toxin","volume":"92","author":"Helting","year":"1984","journal-title":"Acta Pathol Microbiol Immunol Scand [C]"},{"issue":"11","key":"10.1016\/j.vaccine.2007.08.035_bib7","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1128\/IAI.55.11.2541-2545.1987","article-title":"Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli","volume":"55","author":"Fairweather","year":"1987","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2007.08.035_bib8","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/0041-0101(95)00072-T","article-title":"Expression of a large, nontoxic fragment of botulinum neurotoxin serotype A and its use as an immunogen","volume":"33","author":"LaPenotiere","year":"1995","journal-title":"Toxicon"},{"issue":"7","key":"10.1016\/j.vaccine.2007.08.035_bib9","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/IAI.63.7.2738-2742.1995","article-title":"Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli","volume":"63","author":"Clayton","year":"1995","journal-title":"Infect Immun"},{"issue":"16","key":"10.1016\/j.vaccine.2007.08.035_bib10","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/S0264-410X(96)00094-1","article-title":"Mapping of protective and cross-reactive domains of the type A neurotoxin of Clostridium botulinum","volume":"14","author":"Dertzbaugh","year":"1996","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.08.035_bib11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1348-0421.2007.tb03919.x","article-title":"C terminal half fragment (50kDa) of heavy chain components of Clostridium botulinum type C and D neurotoxins can be used as an effective vaccine","volume":"51","author":"Lee","year":"2007","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2007.08.035_bib12","first-page":"16","article-title":"Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxins","volume":"16","author":"Webb","year":"2007","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2007.08.035_bib13","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.toxicon.2006.02.013","article-title":"Recombinant C fragment of botulinum neurotoxin B serotype (rBoNTB (HC)) immune response and protection in the rhesus monkey","volume":"47","author":"Boles","year":"2006","journal-title":"Toxicon"},{"issue":"10","key":"10.1016\/j.vaccine.2007.08.035_bib14","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1128\/IAI.73.10.6998-7005.2005","article-title":"Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E","volume":"73","author":"Baldwin","year":"2005","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2007.08.035_bib15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/BF01886751","article-title":"Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855\u20131296 with antitoxin antibodies from three host species","volume":"15","author":"Atassi","year":"1996","journal-title":"J Protein Chem"},{"issue":"3","key":"10.1016\/j.vaccine.2007.08.035_bib16","first-page":"219","article-title":"Structure, activity, and immune (T and B cell) recognition of botulinum neurotoxins","volume":"19","author":"Atassi","year":"1999","journal-title":"Crit Rev Immunol"},{"issue":"14","key":"10.1016\/j.vaccine.2007.08.035_bib17","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0161-5890(97)00107-7","article-title":"Immune recognition of botulinum neurotoxin type A: regions recognized by T cells and antibodies against the protective H(C) fragment (residues 855\u20131296) of the toxin","volume":"34","author":"Oshima","year":"1997","journal-title":"Mol Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.035_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0165-2478(97)00124-7","article-title":"Antibodies T cells against synthetic peptides of the C-terminal domain (Hc) of botulinum neurotoxin type A and their cross-reaction with Hc","volume":"60","author":"Oshima","year":"1998","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2007.08.035_bib19","first-page":"286","article-title":"New perspectives in adenoviruses","volume":"18","author":"Lukashok","year":"1998","journal-title":"Curr Clin Top Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2007.08.035_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/hum.2005.16.157","article-title":"Adenovirus-based genetic vaccines for biodefense","volume":"16","author":"Boyer","year":"2005","journal-title":"Hum Gene Ther"},{"issue":"23","key":"10.1016\/j.vaccine.2007.08.035_bib21","doi-asserted-by":"crossref","first-page":"11474","DOI":"10.1128\/JVI.75.23.11474-11482.2001","article-title":"Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines","volume":"75","author":"Shi","year":"2001","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.08.035_bib22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nm0697-651","article-title":"Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization","volume":"3","author":"Lubeck","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2007.08.035_bib23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/415331a","article-title":"Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity","author":"Shiver","year":"2002","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.vaccine.2007.08.035_bib24","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1089\/104303403322542310","article-title":"Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigen","volume":"14","author":"Tan","year":"2003","journal-title":"Hum Gene Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.035_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.mt.6300034","article-title":"Adenovirus-based prime-boost immunization for rapid vaccination against anthrax","volume":"15","author":"McConnell","year":"2007","journal-title":"Mol Ther"},{"issue":"5","key":"10.1016\/j.vaccine.2007.08.035_bib26","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","article-title":"A simplified system for generating recombinant adenoviruses","volume":"95","author":"He","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2007.08.035_bib27","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2144\/01312bm04","article-title":"AdEasy system made easier by selecting the viral backbone plasmid preceding homologous recombination","volume":"31","author":"Zeng","year":"2001","journal-title":"Biotechniques"},{"issue":"3","key":"10.1016\/j.vaccine.2007.08.035_bib28","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0006-291X(90)90828-B","article-title":"The complete nucleotide sequence of the gene coding for botulinum type C1 toxin in the C-ST phage genome","volume":"171","author":"Kimura","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10.1016\/j.vaccine.2007.08.035_bib29","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1093\/nar\/30.10.e43","article-title":"DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis","volume":"30","author":"Hoover","year":"2002","journal-title":"Nucleic Acids Res"},{"issue":"22","key":"10.1016\/j.vaccine.2007.08.035_bib30","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1093\/nar\/gng143","article-title":"Thermodynamically balanced inside-out (TBIO) PCR-based gene synthesis: a novel method of primer design for high-fidelity assembly of longer gene sequences","volume":"31","author":"Gao","year":"2003","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.vaccine.2007.08.035_bib31","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1128\/CDLI.11.3.496-502.2004","article-title":"Vaccination with recombinant whole heavy chain fragments of Clostridium botulinum type C and D neurotoxins","volume":"11","author":"Arimitsu","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"18","key":"10.1016\/j.vaccine.2007.08.035_bib32","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1016\/j.vaccine.2007.01.075","article-title":"Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine","volume":"25","author":"Zeng","year":"2007","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2007.08.035_bib33","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1128\/IAI.66.10.4817-4822.1998","article-title":"Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate","volume":"66","author":"Byrne","year":"1998","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2007.08.035_bib34","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1172\/JCI118573","article-title":"Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis","volume":"97","author":"Zabner","year":"1996","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.vaccine.2007.08.035_bib35","doi-asserted-by":"crossref","first-page":"6729","DOI":"10.1128\/JVI.73.8.6729-6742.1999","article-title":"Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs","volume":"73","author":"Harvey","year":"1999","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2007.08.035_bib36","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.1128\/IAI.73.10.6885-6891.2005","article-title":"Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity","volume":"73","author":"Hashimoto","year":"2005","journal-title":"Infect Immun"},{"issue":"17","key":"10.1016\/j.vaccine.2007.08.035_bib37","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0264-410X(99)00253-4","article-title":"Vaccination of mice with DNA encoding a large fragment of botulinum neurotoxin serotype A","volume":"18","author":"Clayton","year":"2000","journal-title":"Vaccine"},{"issue":"29\u201330","key":"10.1016\/j.vaccine.2007.08.035_bib38","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1016\/j.vaccine.2004.04.006","article-title":"Efficacy of DNA vaccines expressing the type F botulinum toxin Hc fragment using different promoters","volume":"22","author":"Jathoul","year":"2004","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2007.08.035_bib39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/viro.1997.8878","article-title":"Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo","volume":"239","author":"Pushko","year":"1997","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.vaccine.2007.08.035_bib40","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1128\/IAI.69.9.5709-5715.2001","article-title":"Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system","volume":"69","author":"Lee","year":"2001","journal-title":"Infect Immun"},{"issue":"47\u201348","key":"10.1016\/j.vaccine.2007.08.035_bib41","doi-asserted-by":"crossref","first-page":"6886","DOI":"10.1016\/j.vaccine.2006.06.004","article-title":"Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice","volume":"24","author":"Lee","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2007.08.035_bib42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1046-2023(03)00134-8","article-title":"Technical issues in construction of nucleic acid vaccines","volume":"31","author":"Ertl","year":"2003","journal-title":"Methods"},{"issue":"37","key":"10.1016\/j.vaccine.2007.08.035_bib43","doi-asserted-by":"crossref","first-page":"13601","DOI":"10.1073\/pnas.0405557101","article-title":"A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores","volume":"101","author":"Hermanson","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.035_bib44","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1099\/0022-1317-40-1-45","article-title":"Infection of mouse liver by human adenovirus type 5","volume":"40","author":"Duncan","year":"1978","journal-title":"J Gen Virol"},{"issue":"13","key":"10.1016\/j.vaccine.2007.08.035_bib45","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1089\/hum.1998.9.13-1909","article-title":"New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses","volume":"9","author":"Fallaux","year":"1998","journal-title":"Hum Gene Ther"},{"issue":"15","key":"10.1016\/j.vaccine.2007.08.035_bib46","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1089\/104303400750001417","article-title":"Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production","volume":"11","author":"Schiedner","year":"2000","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2007.08.035_bib47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10616-006-9023-6","article-title":"A new complementing cell line for replication-incompetent E1-deleted adenovirus propagation","volume":"51","author":"Xu","year":"2006","journal-title":"Cytotechnology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07009693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07009693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T01:53:43Z","timestamp":1684029223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07009693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":47,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0264410X07009693"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.08.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}